{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:07Z","timestamp":1707524647505},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,14]]},"DOI":"10.7759\/cureus.25001","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T19:29:45Z","timestamp":1652556585000},"source":"Crossref","is-referenced-by-count":0,"title":["Decreasing Rates of Fracture-Related Hospitalization With Primary Biliary Cholangitis: Insights From the Nationwide Inpatient Sample"],"prefix":"10.7759","author":[{"given":"Zaid","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishani","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Bhurwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsh","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surabhi","family":"Uppal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indu","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savio","family":"Reddymasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keng-Yu","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin ME","year":"2005","unstructured":"Gershwin ME, Selmi C, Worman HJ, et al.. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005, 42:1194-202. 10.1002\/hep.20907","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1314","article-title":"Burden of primary biliary cholangitis among inpatient population in the United States","volume":"3","author":"Shahab O","year":"2019","unstructured":"Shahab O, Sayiner M, Paik J, Felix S, Golabi P, Younossi ZM. Burden of primary biliary cholangitis among inpatient population in the United States. Hepatol Commun. 2019, 3:356-64. 10.1002\/hep4.1314","journal-title":"Hepatol Commun"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2016.07.005","article-title":"Hospitalizations for osteoporosis-related fractures: economic costs and clinical outcomes","volume":"5","author":"Weycker D","year":"2016","unstructured":"Weycker D, Li X, Barron R, Bornheimer R, Chandler D. Hospitalizations for osteoporosis-related fractures: economic costs and clinical outcomes. Bone Rep. 2016, 5:186-91. 10.1016\/j.bonr.2016.07.005","journal-title":"Bone Rep"},{"key":"ref4","article-title":"Bone Health and Osteoporosis: A Report of the Surgeon General","author":"Office of the Surgeon General (US)","year":"2004","unstructured":"Office of the Surgeon General (US). Bone Health and Osteoporosis: A Report of the Surgeon General. Office of the Surgeon General (US), Rockville (MD); 2004."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2002.50455.x","article-title":"Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study","volume":"50","author":"Leibson CL","year":"2002","unstructured":"Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc. 2002, 50:1644-50. 10.1046\/j.1532-5415.2002.50455.x","journal-title":"J Am Geriatr Soc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i31.3513","article-title":"Osteoporosis in primary biliary cholangitis","volume":"24","author":"Danford CJ","year":"2018","unstructured":"Danford CJ, Trivedi HD, Papamichael K, Tapper EB, Bonder A. Osteoporosis in primary biliary cholangitis. World J Gastroenterol. 2018, 24:3513-20. 10.3748\/wjg.v24.i31.3513","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(82)80292-8","article-title":"Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D","volume":"83","author":"Herlong HF","year":"1982","unstructured":"Herlong HF, Recker RR, Maddrey WC. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology. 1982, 83:103-8.","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283405939","article-title":"Osteoporosis in patients with primary biliary cirrhosis","volume":"22","author":"Wariaghli G","year":"2010","unstructured":"Wariaghli G, Allali F, El Maghraoui A, Hajjaj-Hassouni N. Osteoporosis in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 2010, 22:1397-401. 10.1097\/MEG.0b013e3283405939","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey EJ","year":"2015","unstructured":"Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015, 386:P1565-75. 10.1016\/S0140-6736(15)00154-3","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-007-0833-1","article-title":"Primary biliary cirrhosis and osteoporosis: a case-control study","volume":"26","author":"Mounach A","year":"2008","unstructured":"Mounach A, Ouzzif Z, Wariaghli G, et al.. Primary biliary cirrhosis and osteoporosis: a case-control study. J Bone Miner Metab. 2008, 26:379-84. 10.1007\/s00774-007-0833-1","journal-title":"J Bone Miner Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2016.02.009","article-title":"Metabolic bone disease in primary biliary cirrhosis","volume":"45","author":"Glass LM","year":"2016","unstructured":"Glass LM, Su GL. Metabolic bone disease in primary biliary cirrhosis. Gastroenterol Clin North Am. 2016, 45:333-43. 10.1016\/j.gtc.2016.02.009","journal-title":"Gastroenterol Clin North Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.22.2815","article-title":"Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment","volume":"286","author":"Siris ES","year":"2001","unstructured":"Siris ES, Miller PD, Barrett-Connor E, et al.. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001, 286:2815-22. 10.1001\/jama.286.22.2815","journal-title":"JAMA"},{"key":"ref13","article-title":"Factors influencing the development of metabolic bone disease in primary biliary cirrhosis","volume":"85","author":"Gua\u00f1abens N","year":"1990","unstructured":"Gua\u00f1abens N, Par\u00e9s A, Mari\u00f1oso L, et al.. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol. 1990, 85:1356-62.","journal-title":"Am J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.09.012","article-title":"Fracture risk in people with primary biliary cirrhosis: a population-based cohort study","volume":"131","author":"Solaymani-Dodaran M","year":"2006","unstructured":"Solaymani-Dodaran M, Card TR, Aithal GP, West J. Fracture risk in people with primary biliary cirrhosis: a population-based cohort study. Gastroenterology. 2006, 131:1752-7. 10.1053\/j.gastro.2006.09.012","journal-title":"Gastroenterology"},{"key":"ref15","unstructured":"Agency for Healthcare Research and Quality (US). Facts and figures. Statistics on hospital-based care in the United States, 2007. (2009). https:\/\/www.hcup-us.ahrq.gov\/reports.jsp."},{"key":"ref16","unstructured":"HCUP Databases. Healthcare Cost and Utilization Project (HCUP). (2019). http.\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280315","article-title":"Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis","volume":"28","author":"Gallego-Rojo FJ","year":"1998","unstructured":"Gallego-Rojo FJ, Gonzalez-Calvin JL, Mu\u00f1oz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology. 1998, 28:695-9. 10.1002\/hep.510280315","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1760339","article-title":"Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture","volume":"176","author":"Koshihara Y","year":"2003","unstructured":"Koshihara Y, Hoshi K, Okawara R, Ishibashi H, Yamamoto S. Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J Endocrinol. 2003, 176:339-48. 10.1677\/joe.0.1760339","journal-title":"J Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117959","article-title":"Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice","volume":"95","author":"Janes CH","year":"1995","unstructured":"Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest. 1995, 95:2581-6. 10.1172\/JCI117959","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2009.02230.x","article-title":"Lithocholic acid downregulates vitamin D effects in human osteoblasts","volume":"40","author":"Ruiz-Gasp\u00e0 S","year":"2010","unstructured":"Ruiz-Gasp\u00e0 S, Gua\u00f1abens N, Enjuanes A, et al.. Lithocholic acid downregulates vitamin D effects in human osteoblasts. Eur J Clin Invest. 2010, 40:25-34. 10.1111\/j.1365-2362.2009.02230.x","journal-title":"Eur J Clin Invest"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.080313","article-title":"Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation","volume":"23","author":"Kawelke N","year":"2008","unstructured":"Kawelke N, Bentmann A, Hackl N, et al.. Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation. J Bone Miner Res. 2008, 23:1278-86. 10.1359\/jbmr.080313","journal-title":"J Bone Miner Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.02.016","article-title":"Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis","volume":"138","author":"Gua\u00f1abens N","year":"2010","unstructured":"Gua\u00f1abens N, Cerd\u00e1 D, Monegal A, Pons F, Caballer\u00eda L, Peris P, Par\u00e9s A. Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis. Gastroenterology. 2010, 138:2348-56. 10.1053\/j.gastro.2010.02.016","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50106","article-title":"AGA technical review on osteoporosis in gastrointestinal diseases","volume":"124","author":"Bernstein CN","year":"2003","unstructured":"Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003, 124:795-841. 10.1053\/gast.2003.50106","journal-title":"Gastroenterology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840040215","article-title":"Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease","volume":"4","author":"Bengoa JM","year":"1984","unstructured":"Bengoa JM, Sitrin MD, Meredith S, Kelly SE, Shah N, Baker AL, Rosenberg IH. Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease. Hepatology. 1984, 4:261-5. 10.1002\/hep.1840040215","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.2.282","article-title":"Osteoporosis in primary biliary cirrhosis revisited","volume":"49","author":"Newton J","year":"2001","unstructured":"Newton J, Francis R, Prince M, James O, Bassendine M, Rawlings D, Jones D. Osteoporosis in primary biliary cirrhosis revisited. Gut. 2001, 49:282-7. 10.1136\/gut.49.2.282","journal-title":"Gut"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(00)80118-x","article-title":"Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial","volume":"33","author":"Lindor KD","year":"2000","unstructured":"Lindor KD, Jorgensen RA, Tiegs RD, Khosla S, Dickson ER. Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial. J Hepatol. 2000, 33:878-82. 10.1016\/s0168-8278(00)80118-x","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-8015-x","article-title":"Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen\/progestin","volume":"51","author":"Boone RH","year":"2006","unstructured":"Boone RH, Cheung AM, Girlan LM, Heathcote EJ. Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen\/progestin. Dig Dis Sci. 2006, 51:1103-12. 10.1007\/s10620-006-8015-x","journal-title":"Dig Dis Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2015.01.005","article-title":"DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women","volume":"18","author":"Overman RA","year":"2015","unstructured":"Overman RA, Farley JF, Curtis JR, Zhang J, Gourlay ML, Deal CL. DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women. J Clin Densitom. 2015, 18:145-9. 10.1016\/j.jocd.2015.01.005","journal-title":"J Clin Densitom"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2565","article-title":"Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996-2012: an ecological analysis","volume":"30","author":"Jha S","year":"2015","unstructured":"Jha S, Wang Z, Laucis N, Bhattacharyya T. Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996-2012: an ecological analysis. J Bone Miner Res. 2015, 30:2179-87. 10.1002\/jbmr.2565","journal-title":"J Bone Miner Res"},{"key":"ref30","article-title":"Hospitalization for total hip replacement among inpatients aged 45 and over: United States, 2000-2010","author":"Wolford ML","year":"2015","unstructured":"Wolford ML, Palso K, Bercovitz A. Hospitalization for total hip replacement among inpatients aged 45 and over: United States, 2000-2010. NCHS Data Brief. 2015, 1-8.","journal-title":"NCHS Data Brief"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis","volume":"42","author":"Gua\u00f1abens N","year":"2005","unstructured":"Gua\u00f1abens N, Par\u00e9s A, Ros I, et al.. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol. 2005, 42:573-7. 10.1016\/j.jhep.2004.11.035","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47890-2","article-title":"Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort","volume":"9","author":"Marschall HU","year":"2019","unstructured":"Marschall HU, Henriksson I, Lindberg S, S\u00f6derdahl F, Thuresson M, Wahlin S, Ludvigsson JF. Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort. Sci Rep. 2019, 9:11525. 10.1038\/s41598-019-47890-2","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra K","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012, 56:1181-8. 10.1016\/j.jhep.2011.10.025","journal-title":"J Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-220824","article-title":"Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis","volume":"2017","author":"Polychronopoulou E","year":"2017","unstructured":"Polychronopoulou E, Lygoura V, Gatselis NK, Dalekos GN. Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis. BMJ Case Rep. 2017, 2017:bcr2017220824. 10.1136\/bcr-2017-220824","journal-title":"BMJ Case Rep"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4172\/2167-0889.1000154","article-title":"Coexistence of primary biliary cirrhosis and inflammatory bowel disease","volume":"3","author":"Toru S","year":"2014","unstructured":"Toru S. Coexistence of primary biliary cirrhosis and inflammatory bowel disease. J Liver. 2014, 3:3. 10.4172\/2167-0889.1000154","journal-title":"J Liver"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1433-9","article-title":"Fracture-associated hospitalizations in patients with inflammatory bowel disease","volume":"56","author":"Ananthakrishnan AN","year":"2011","unstructured":"Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Fracture-associated hospitalizations in patients with inflammatory bowel disease. Dig Dis Sci. 2011, 56:176-82. 10.1007\/s10620-010-1433-9","journal-title":"Dig Dis Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/90354-decreasing-rates-of-fracture-related-hospitalization-with-primary-biliary-cholangitis-insights-from-the-nationwide-inpatient-sample","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:20Z","timestamp":1707507320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/90354-decreasing-rates-of-fracture-related-hospitalization-with-primary-biliary-cholangitis-insights-from-the-nationwide-inpatient-sample"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,14]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.25001","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,14]]}}}